ANAGRAM THERAPEUTICS Trademark

Trademark Overview


On Friday, April 28, 2023, a trademark application was filed for ANAGRAM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ANAGRAM THERAPEUTICS trademark a serial number of 97913497. The federal status of this trademark filing is REGISTERED as of Tuesday, March 31, 2026. This trademark is owned by Anagram Therapeutics, Inc.. The ANAGRAM THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of malabsorption syndromes, nutrient metabolism disorders, rare diseases, congenital disorders, pancreatic diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders and inflammatory diseases and disorders

Research and development in the field of oral enzyme therapies; pharmaceutical research and development services; providing scientific research information in the field of pharmaceuticals, oral enzyme therapies, and clinical trials; research and development of pharmaceuticals and therapeutics for the treatment of malabsorption syndromes, nutrient metabolism disorders, rare diseases, congenital disorders, pancreatic diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders and inflammatory diseases and disorders
anagram therapeutics

General Information


Serial Number97913497
Word MarkANAGRAM THERAPEUTICS
Filing DateFriday, April 28, 2023
Status700 - REGISTERED
Status DateTuesday, March 31, 2026
Registration Number8196638
Registration DateTuesday, March 31, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical preparations for the treatment of malabsorption syndromes, nutrient metabolism disorders, rare diseases, congenital disorders, pancreatic diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders and inflammatory diseases and disorders
Goods and ServicesResearch and development in the field of oral enzyme therapies; pharmaceutical research and development services; providing scientific research information in the field of pharmaceuticals, oral enzyme therapies, and clinical trials; research and development of pharmaceuticals and therapeutics for the treatment of malabsorption syndromes, nutrient metabolism disorders, rare diseases, congenital disorders, pancreatic diseases and disorders, gastrointestinal diseases and disorders, metabolic diseases and disorders and inflammatory diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 28, 2023
Primary Code005
First Use Anywhere DateTuesday, February 28, 2023
First Use In Commerce DateTuesday, February 28, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, May 28, 2023
Primary Code042
First Use Anywhere DateTuesday, February 28, 2023
First Use In Commerce DateTuesday, February 28, 2023

Trademark Owner History


Party NameAnagram Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760
US

Party NameAnagram Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNatick, MA 01760
US

Party NameAnagram Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFramingham, MA 01701
US

Trademark Events


Event DateEvent Description
Tuesday, May 2, 2023NEW APPLICATION ENTERED
Sunday, May 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 25, 2024ASSIGNED TO EXAMINER
Tuesday, January 30, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 30, 2024EXAMINERS AMENDMENT E-MAILED
Tuesday, January 30, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 30, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, January 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2024SOU EXTENSION 1 FILED
Tuesday, November 5, 2024SOU EXTENSION 1 GRANTED
Tuesday, November 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 2, 2025SOU TEAS EXTENSION RECEIVED
Saturday, May 3, 2025SOU EXTENSION 2 FILED
Saturday, May 3, 2025SOU EXTENSION 2 GRANTED
Saturday, May 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 17, 2025SOU TEAS EXTENSION RECEIVED
Friday, October 17, 2025TEAS STATEMENT OF USE RECEIVED
Friday, October 17, 2025SOU EXTENSION 3 FILED
Wednesday, March 11, 2026SOU EXTENSION 3 GRANTED
Friday, October 17, 2025USE AMENDMENT FILED
Wednesday, March 11, 2026STATEMENT OF USE PROCESSING COMPLETE
Thursday, March 12, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 12, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 12, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 31, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, March 31, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED